These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9267134)

  • 1. [A case of fulminant hepatitis caused by antiandrogen, flutamide in a patient with prostate cancer].
    Satoh T; Egawa S; Katsuta M; Iwamura M; Uchida T; Koshiba K
    Nihon Hinyokika Gakkai Zasshi; 1997 Jul; 88(7):694-6. PubMed ID: 9267134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide-induced acute renal failure in a patient with metastatic prostate cancer.
    Altiparmak MR; Bilici A; Kisacik B; Ozguroglu M
    Med Oncol; 2002; 19(2):117-9. PubMed ID: 12180480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
    Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
    J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fulminant hepatitis associated with treatment with flutamide].
    García-Gascó P; Morata Aldea C; Segura Huertas A; Aparicio Urtasun J
    Med Clin (Barc); 1997 Dec; 109(20):820. PubMed ID: 9493166
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.
    Gomez JL; Dupont A; Cusan L; Tremblay M; Suburu R; Lemay M; Labrie F
    Am J Med; 1992 May; 92(5):465-70. PubMed ID: 1349790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flutamide-induced acute hepatitis: investigation on the role of immunoallergic mechanisms.
    Pontiroli L; Sartori M; Pittau S; Morelli S; Boldorini R; Albano E
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):310-4. PubMed ID: 9759603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flutamide-induced acute hepatitis in advanced prostate cancer patients.
    Kraus I; Vitezic D; Oguic R
    Int J Clin Pharmacol Ther; 2001 Sep; 39(9):395-9. PubMed ID: 11563686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
    Rosenthal SA; Linstadt DE; Leibenhaut MH; Andras EJ; Brooks CP; Stickney DR; Chang GC; Wolkov HB; Gilbert RM
    Radiology; 1996 May; 199(2):451-5. PubMed ID: 8668793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.
    Pu YS; Liu CM; Kao JH; Chen J; Lai MK
    Eur Urol; 1999 Oct; 36(4):293-7. PubMed ID: 10473987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in liver function induced by flutamide in patients with prostate cancer (studies in patients treated with total androgen blockage)].
    Ikemoto I; Ohishi Y; Yamazaki H; Wada T; Aizawa Y
    Nihon Hinyokika Gakkai Zasshi; 2000 Jun; 91(6):556-61. PubMed ID: 10897581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatoxicity caused by flutamide increased by hypotensive situation?].
    Serrano Hernández N; García López F; Fedriani Gorria J
    An Med Interna; 1996 Nov; 13(11):552-4. PubMed ID: 9019217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flutamide-associated acute liver failure.
    Famularo G; De Simone C; Minisola G; Nicotra GC
    Ann Ital Med Int; 2003; 18(4):250-3. PubMed ID: 14971714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy of prostatic bone metastases.
    Huben RP
    Adv Exp Med Biol; 1992; 324():305-16. PubMed ID: 1492625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
    Eisenberger MA; Blumenstein BA; Crawford ED; Miller G; McLeod DG; Loehrer PJ; Wilding G; Sears K; Culkin DJ; Thompson IM; Bueschen AJ; Lowe BA
    N Engl J Med; 1998 Oct; 339(15):1036-42. PubMed ID: 9761805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxic hepatitis after flutamide treatment].
    Bengoechea Gallastegui L; Vita Garay A; Castiella Eguzkiza A; Egido Arroyo JF
    Aten Primaria; 2005 Jun; 36(2):112. PubMed ID: 15989835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Liver failure caused by flutamide].
    Guzmán Martínez-Valls PL; Ferrero Doria R; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Gil Franco J; Fontana Compiano LO
    Actas Urol Esp; 1997 Mar; 21(3):278-82. PubMed ID: 9324896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fulminant hepatitis after flutamide treatment.
    Dourakis SP; Alexopoulou AA; Hadziyannis SJ
    J Hepatol; 1994 Mar; 20(3):350-3. PubMed ID: 8014445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of flutamide-induced acute cholestatic hepatitis--a case report.
    Lee HW; Chung JP; Lee KS; Kim KC; Lee KS; Chon CY; Park IS; Kim HG
    Yonsei Med J; 1996 Jun; 37(3):225-9. PubMed ID: 8826789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group.
    Schellhammer P; Sharifi R; Block N; Soloway M; Venner P; Patterson AL; Sarosdy M; Vogelzang N; Jones J; Kolvenbag G
    Urology; 1996 Jan; 47(1A Suppl):54-60; discussion 80-4. PubMed ID: 8560679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.